Hyperinsulinemia and left ventricular geometry in a work-site population in Japan

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 729-734

  Ohya, Yusuke ^a   Abe, Isao ^b   Fujii, Koji ^b   Ohmori, Susumu ^b   Onaka, Uran ^b   Kobayashi, Kazuo ^b   Fujishima, Masatoshi ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

echocardiography; hyperglycemia; hyperinsulinism; hypertrophy, left ventricular; obesity

Indexed keywords

GLUCOSE; INSULIN;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GEOMETRY; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; OBESITY; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0029966734     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.729     Document Type: Conference Paper

References (34)

1. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med. 1986;105: 173-178.
2. Levy D, Garisson RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically detected left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322: 1561-1566.
3. Koren MJ, Devereux RB, Casake PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1992;114:345-352.
4. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. JAMA. 1991;266:231-236.
5. Ganau A, Devereux RB, Roman MJ, Giovanni S, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550-1558.
6. Gottdiener JS, Komenic JR, Materson BJ, Massie BM, Notargiacomo A, Hamburger RJ, Williams DW, Henderson WG. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. J Am Coll Cardiol. 1994;24: 1492-1498.
7. de Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 1994;23: 600-606.
8. Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol. 1991;68:85-89.
9. Grossman E, Shemesh J, Shamiss A, Thaler M, Carroll J, Rosenthal T. Left ventricular mass in diabetes-hypertension. Arch Intern Med. 1992;152:1001-1004.
10. Hara-Nakamura N, Kohara K, Sumimoto T, Lin M, Hiwada K. Glucose intolerance exaggerates left ventricular hypertrophy and dysfunction in essential hypertension. Am J Hypertens. 1994;7: 1110-1114.
11. Nagano N, Nagano M, Yo Y, Iiyama K, Higaki J, Mikami H, Ogihara T. Role of glucose intolerance in cardiac diastolic function in essential hypertension. Hypertension. 1994;23:1002-1005.
12. Pedrinelli R, Bello VD, Catapano G, Talarico L, Materazzi F, Santoro G, Giusti C, Mosca F, Melillo E, Ferrari M. Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients. Arterioscler Thromb. 1993;13:900-906.
13. Sharp SD, Williams RR. Fasting insulin and left ventricular mass in hypertensives and normotensive controls. Cardiology. 1992;81: 207-212.
14. Sasson Z, Rasooly Y, Bhesania T, Rasooly I. Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation. 1993;88:1431-1436.
15. Lind L, Andersson PE, Andren B, Hanni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens. 1995;13: 433-438.
16. Hollenbeck CB, Chen N, Chen YDI, Reaven GM. Relationship between the plasma insulin response to oral glucose and insulin stimulated glucose utilization in normal subjects. Diabetes. 1984;33: 460-463.
17. Reaven GM, Brand RJ, Chen Y-DI, Mathur AK, Goldfine I. Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes. 1993;42: 1324-1332.
18. Devereux RB, Reichek N. Echocardiographic determinant of left ventricular mass in man: anatomic validation of the method. Circulation. 1987;55:613-618.
19. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Alderman MH. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20: 1251-1260.
20. Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation. 1995;91:2400-2406.
21. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problem in echocardiographic volume determinations: echocardiographic and angiographic correlations in the presence or absence of asynergy. Am J Cardiol. 1976;37:7-11.
22. World Health Organization. Impaired glucose tolerance and diabetes: WHO criteria. Br Med J. 1985;6:45-86.
23. Hammond IW, Devereux RB, Alderman MH, Laragh JH. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol. 1988;12:996-1004.
24. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, DeGregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BJ, Bogardus C. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 1991;324:733-739.
25. Ferrannini E, Haffner SM, Stern MP. Hypertension: an insulin-resistant state. J Cardiovasc Pharmacol. 1990;15(suppl 5):S18-S25.
26. Hill DJ, Milner DG. Insulin as a growth factor. Pediatr Res. 1985;19: 879-886.
27. Rocchini AP, Katch V, Kveselis D, Moorehead C, Martin M, Lampman R, Gregoruy M. Insulin and renal sodium retention in obese adolescents. Hypertension. 1989;14:367-374.
28. Landsberg L, Crier DR. Obesity, metabolism and the sympathetic nervous system. Am J Hypertens. 1989;2:125S-132S.
29. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, Faud-Tarazi F, Horan MJ, Marcus M, Massie B, Pfeffer MA, Re RN, Roccella EJ, Savage D, Shub C. The heart in hypertension. N Engl J Med. 1992;327:998-1008.
30. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, Santucci A, Santucci C, Reboldi G, Porcellati C. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol. 1995;25:871-878.
31. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol. 1995;25:879-884.
32. Ohmori S, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Nomiyama K, Yoshitake T, Ueda K, Fujishima M. Hyperinsulinemia and blood pressure in a general Japanese population: the Hisayama Study. J Hypertens. 1994;12:1191-1197.
33. Devereux RB, Howard BV, Roman MJ, Lee ET, O'Grady MJ, Fabsitz RR, Paranicas M, Yeh J, Welty TK. Relation of diabetes and impaired glucose tolerance to left ventricular structure and function in Arizona Indians: the Strong Heart Study. Circulation. 1995;92(suppl):I-419. Abstract.
34. Blake J, Devereux RB, Borer JS, Szulc M, Pappas TW, Laragh JH. Relation of obesity, high sodium intake, and eccentric left ventricular hypertrophy to left ventricular exercise dysfunction in essential hypertension. Am J Med. 1990;88:477-485.